These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12144980)

  • 1. Hepatitis C screening and management practices: a survey of drug treatment and syringe exchange programs in New York City.
    Pratt CC; Paone D; Carter RJ; Layton MC
    Am J Public Health; 2002 Aug; 92(8):1254-6. PubMed ID: 12144980
    [No Abstract]   [Full Text] [Related]  

  • 2. Harm reduction product distribution in British Columbia.
    Harvard SS; Hill WD; Buxton JA
    Can J Public Health; 2008; 99(6):446-50. PubMed ID: 19149383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug injection rates and needle-exchange use in New York City, 1991-1996.
    Marmor M; Shore RE; Titus S; Chen X; Des Jarlais DC
    J Urban Health; 2000 Sep; 77(3):359-68. PubMed ID: 10976610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Injecting drug use in Australia: needle/syringe programs prove their worth, but hepatitis C still on the increase.
    Copeman M
    Med J Aust; 2003 Jul; 179(2):119; author reply 119. PubMed ID: 12864712
    [No Abstract]   [Full Text] [Related]  

  • 5. Knowledge of hepatitis among active drug injectors at a syringe exchange program.
    Carey J; Perlman DC; Friedmann P; Kaplan WM; Nugent A; Deutscher M; Masson CL; Des Jarlais DC
    J Subst Abuse Treat; 2005 Jul; 29(1):47-53. PubMed ID: 15979531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving the quality of needle and syringe programmes: an overlooked strategy for preventing hepatitis C among people who inject drugs.
    Leicht A
    BMC Infect Dis; 2014; 14 Suppl 6(Suppl 6):S8. PubMed ID: 25252714
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatitis C infection among injecting drug users in Scotland: stemming the flow.
    Goldberg D; Taylor A; Hutchinson S; McMenamin J
    Scott Med J; 2000 Oct; 45(5):131-2. PubMed ID: 11130293
    [No Abstract]   [Full Text] [Related]  

  • 8. Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program.
    Hagan H; Jarlais DC; Friedman SR; Purchase D; Alter MJ
    Am J Public Health; 1995 Nov; 85(11):1531-7. PubMed ID: 7485666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Injection drug users and the provision of hepatitis C-related services in a nationwide sample of drug treatment programs.
    Vassilev ZP; Strauss SM; Astone J; Des Jarlais DC
    J Behav Health Serv Res; 2004; 31(2):208-16. PubMed ID: 15255228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prison-based syringe exchange programmes: a review of international research and development.
    Dolan K; Rutter S; Wodak AD
    Addiction; 2003 Feb; 98(2):153-8. PubMed ID: 12534419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thinking ethically about needle and syringe programs.
    Kleinig J
    Subst Use Misuse; 2006; 41(6-7):815-25. PubMed ID: 16809168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is point of access to needles and syringes related to needle sharing? Comparing data collected from pharmacies and needle and syringe programs in south-east Sydney.
    Bryant J; Topp L; Hopwood M; Iversen J; Treloar C; Maher L
    Drug Alcohol Rev; 2010 Jul; 29(4):364-70. PubMed ID: 20636651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a needle social marketing strategy to control HIV among injecting drug users in China.
    Wu Z; Luo W; Sullivan SG; Rou K; Lin P; Liu W; Ming Z
    AIDS; 2007 Dec; 21 Suppl 8():S115-22. PubMed ID: 18172379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus antibody prevalence among injecting drug users in Glasgow has fallen but remains high.
    Goldberg D; Cameron S; McMenamin J
    Commun Dis Public Health; 1998 Jun; 1(2):95-7. PubMed ID: 9644121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examining Social-Ecological Factors in Developing the Louisville Metro Department of Public Health and Wellness Syringe Exchange Program.
    Kerr J; Atlas M; Crabtree W; Chen YT; Moyer S
    Am J Public Health; 2019 Mar; 109(3):454-457. PubMed ID: 30726148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syringe exchange, injecting and intranasal drug use.
    Des Jarlais DC; Arasteh K; McKnight C; Ringer M; Friedman SR
    Addiction; 2010 Jan; 105(1):155-8. PubMed ID: 19891668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex, drugs, and syringe exchange in New York City: women's experiences.
    Paone D; Caloir S; Shi Q; Des Jarlais DC
    J Am Med Womens Assoc (1972); 1995; 50(3-4):109-14. PubMed ID: 7657943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rethinking coverage of needle exchange programs.
    Burrows D
    Subst Use Misuse; 2006; 41(6-7):1045-8. PubMed ID: 16809186
    [No Abstract]   [Full Text] [Related]  

  • 19. Injecting drug use in Australia: needle/syringe programs prove their worth, but hepatitis C still on the increase.
    Law MG; Batey RG
    Med J Aust; 2003 Mar; 178(5):197-8. PubMed ID: 12603178
    [No Abstract]   [Full Text] [Related]  

  • 20. Missed opportunities for hepatitis C testing in opioid treatment programs.
    Frimpong JA
    Am J Public Health; 2013 Jun; 103(6):1028-30. PubMed ID: 23597374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.